Published on September 30, 2025 by Alexis Behra
Sector Summary: Viral Vectors
In 2025, France BioLead brought together over a hundred academic and industrial experts through its Technological Meetings to identify high-value R&D priorities, associated technological challenges, and key French stakeholders.
Co-organized with the Bioproduction & Biotherapies Integrators Network (RIBB) and the PEPR Biothérapies, these Meetings were structured by families of biomedicines.
Explore our dedicated Sector Summary on viral vectors. It outlines the technological challenges related to therapy types and manufacturing processes, analyzes priority R&D areas, and maps out key French stakeholders.
These summaries will be updated periodically, and we would be delighted to receive your feedback.
